|
⚲
|
| Keyboard |
| Avalon BioVentures I LP
✚
|
|
|---|---|
| CIK # | 0001873935 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001873935] | |
| D | [0001873935] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Avalon BioVentures SPV I LP | |
| Lichter Jay | |
| Janux Therapeutics Inc | |
| Avalon Ventures XI LP | |
| Avalon BioVentures I LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 104,957 | $44.75 | 4,696,826 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 541,824 | $44.75 | 24,246,624 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 102,732 | $50.30 | 5,167,420 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 19,900 | $50.30 | 1,000,970 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 104,892 | $50.30 | 5,276,068 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 15,462 | $51.18 | 791,345 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 2,995 | $51.18 | 153,284 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 15,788 | $51.18 | 808,030 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-18 | Sell | 553,219 | $44.75 | 24,756,550 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-17 | Option exercise | 836 | $17.00 | 14,212 |
|
Janux Therapeutics Inc JANX
Stock Option (right to buy) · derivative
|
2024-10-17 | Option exercise | 348 | $0.00 | |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-17 | Option exercise | 348 | $10.73 | 3,734 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-17 | Option exercise | 348 | $13.22 | 4,601 |
|
Janux Therapeutics Inc JANX
Stock Option (right to buy) · derivative
|
2024-10-17 | Option exercise | 836 | $0.00 | |
|
Janux Therapeutics Inc JANX
Stock Option (right to buy) · derivative
|
2024-10-17 | Option exercise | 237 | $0.00 | |
|
Janux Therapeutics Inc JANX
Stock Option (right to buy) · derivative
|
2024-10-17 | Option exercise | 348 | $0.00 | |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-17 | Sell | 1,843 | $50.02 | 92,187 |
|
Janux Therapeutics Inc JANX
Common Stock
|
2024-10-17 | Option exercise | 237 | $39.80 | 9,433 |
|
Janux Therapeutics Inc JANX
Stock Option (right to buy) · derivative
|
2024-10-16 | Option exercise | 2,070 | $0.00 | |
|
Janux Therapeutics Inc JANX
Stock Option (right to buy) · derivative
|
2024-10-16 | Option exercise | 4,968 | $0.00 | |
| showing 20 of 97 most recent transactions | |||||